nodes	percent_of_prediction	percent_of_DWPC	metapath
Ziprasidone—HTR7—sympathetic nervous system—adrenal gland cancer	0.0273	0.134	CbGeAlD
Ziprasidone—HTR7—vein—adrenal gland cancer	0.0255	0.125	CbGeAlD
Ziprasidone—HTR2A—sympathetic nervous system—adrenal gland cancer	0.017	0.0834	CbGeAlD
Ziprasidone—HTR2A—vein—adrenal gland cancer	0.0159	0.078	CbGeAlD
Ziprasidone—CYP1A2—urine—adrenal gland cancer	0.0119	0.0584	CbGeAlD
Ziprasidone—HTR2A—urine—adrenal gland cancer	0.00932	0.0457	CbGeAlD
Ziprasidone—CYP3A4—urine—adrenal gland cancer	0.00863	0.0423	CbGeAlD
Ziprasidone—CYP2D6—urine—adrenal gland cancer	0.00849	0.0416	CbGeAlD
Ziprasidone—H1F0—adrenal cortex—adrenal gland cancer	0.00642	0.0315	CbGeAlD
Ziprasidone—H1F0—gonad—adrenal gland cancer	0.00532	0.0261	CbGeAlD
Ziprasidone—H1F0—cardiac atrium—adrenal gland cancer	0.00531	0.026	CbGeAlD
Ziprasidone—H1F0—pituitary gland—adrenal gland cancer	0.00519	0.0254	CbGeAlD
Ziprasidone—H1F0—adrenal gland—adrenal gland cancer	0.00463	0.0227	CbGeAlD
Ziprasidone—ADRA2C—adrenal cortex—adrenal gland cancer	0.00364	0.0178	CbGeAlD
Ziprasidone—HTR7—gonad—adrenal gland cancer	0.00328	0.0161	CbGeAlD
Ziprasidone—KCNH2—cardiac atrium—adrenal gland cancer	0.00305	0.015	CbGeAlD
Ziprasidone—DRD2—pituitary gland—adrenal gland cancer	0.00303	0.0148	CbGeAlD
Ziprasidone—ADRA2C—cardiac atrium—adrenal gland cancer	0.00301	0.0148	CbGeAlD
Ziprasidone—HTR1A—adrenal gland—adrenal gland cancer	0.00299	0.0147	CbGeAlD
Ziprasidone—KCNH2—pituitary gland—adrenal gland cancer	0.00298	0.0146	CbGeAlD
Ziprasidone—ADRA2C—pituitary gland—adrenal gland cancer	0.00294	0.0144	CbGeAlD
Ziprasidone—Aripiprazole—ABCB1—adrenal gland cancer	0.00289	0.395	CrCbGaD
Ziprasidone—Trazodone—ABCB1—adrenal gland cancer	0.00288	0.393	CrCbGaD
Ziprasidone—HTR7—adrenal gland—adrenal gland cancer	0.00286	0.014	CbGeAlD
Ziprasidone—ADRA1A—adrenal gland—adrenal gland cancer	0.00276	0.0135	CbGeAlD
Ziprasidone—KCNH2—adrenal gland—adrenal gland cancer	0.00266	0.0131	CbGeAlD
Ziprasidone—ADRA2C—adrenal gland—adrenal gland cancer	0.00263	0.0129	CbGeAlD
Ziprasidone—ADRA2A—gonad—adrenal gland cancer	0.00241	0.0118	CbGeAlD
Ziprasidone—ADRA2A—cardiac atrium—adrenal gland cancer	0.0024	0.0118	CbGeAlD
Ziprasidone—ADRA2A—pituitary gland—adrenal gland cancer	0.00235	0.0115	CbGeAlD
Ziprasidone—HRH1—adrenal gland—adrenal gland cancer	0.00213	0.0105	CbGeAlD
Ziprasidone—ADRA2A—adrenal gland—adrenal gland cancer	0.0021	0.0103	CbGeAlD
Ziprasidone—HTR2A—gonad—adrenal gland cancer	0.00205	0.01	CbGeAlD
Ziprasidone—HTR2A—pituitary gland—adrenal gland cancer	0.002	0.00978	CbGeAlD
Ziprasidone—HTR2A—adrenal gland—adrenal gland cancer	0.00178	0.00874	CbGeAlD
Ziprasidone—Clozapine—ABCB1—adrenal gland cancer	0.00156	0.212	CrCbGaD
Ziprasidone—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000113	0.000143	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000113	0.000143	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000113	0.000143	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000113	0.000143	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000112	0.000142	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TERT—adrenal gland cancer	0.000112	0.000142	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000112	0.000142	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—BAD—adrenal gland cancer	0.000112	0.000142	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000111	0.000141	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000111	0.00014	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.00011	0.000139	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—BAD—adrenal gland cancer	0.00011	0.000139	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.00011	0.000139	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000108	0.000138	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000108	0.000137	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000107	0.000136	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	0.000107	0.000136	CbGpPWpGaD
Ziprasidone—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000106	0.000135	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—POMC—adrenal gland cancer	0.000106	0.000134	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—POMC—adrenal gland cancer	0.000106	0.000134	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000106	0.000134	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000106	0.000134	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000105	0.000134	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	0.000105	0.000133	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000105	0.000133	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000105	0.000133	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	0.000105	0.000133	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	0.000105	0.000133	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000104	0.000132	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000104	0.000132	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	0.000104	0.000132	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000104	0.000132	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000103	0.000131	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	0.000103	0.000131	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000103	0.000131	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	0.000103	0.000131	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	0.000102	0.00013	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000102	0.00013	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000102	0.000129	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000102	0.000129	CbGpPWpGaD
Ziprasidone—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	0.000101	0.000129	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—POMC—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000101	0.000128	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.0001	0.000127	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.0001	0.000127	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.0001	0.000127	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	0.0001	0.000127	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.0001	0.000127	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	9.98e-05	0.000127	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	9.98e-05	0.000127	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	9.97e-05	0.000126	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	9.94e-05	0.000126	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—BAD—adrenal gland cancer	9.9e-05	0.000125	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	9.88e-05	0.000125	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	9.87e-05	0.000125	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	9.86e-05	0.000125	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	9.86e-05	0.000125	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	9.85e-05	0.000125	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	9.82e-05	0.000124	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	9.8e-05	0.000124	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	9.8e-05	0.000124	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	9.78e-05	0.000124	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	9.76e-05	0.000124	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—BAD—adrenal gland cancer	9.76e-05	0.000124	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	9.73e-05	0.000123	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	9.73e-05	0.000123	CbGpPWpGaD
Ziprasidone—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	9.7e-05	0.000123	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	9.64e-05	0.000122	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	9.61e-05	0.000122	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	9.58e-05	0.000122	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	9.57e-05	0.000121	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	9.57e-05	0.000121	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	9.47e-05	0.00012	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	9.45e-05	0.00012	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—POMC—adrenal gland cancer	9.35e-05	0.000119	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	9.32e-05	0.000118	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	9.24e-05	0.000117	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	9.16e-05	0.000116	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	9.16e-05	0.000116	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.14e-05	0.000116	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—POMC—adrenal gland cancer	9.12e-05	0.000116	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—POMC—adrenal gland cancer	9.08e-05	0.000115	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	9.01e-05	0.000114	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—POMC—adrenal gland cancer	9e-05	0.000114	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	8.93e-05	0.000113	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	8.89e-05	0.000113	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	8.82e-05	0.000112	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	8.8e-05	0.000112	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	8.77e-05	0.000111	CbGpPWpGaD
Ziprasidone—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	8.73e-05	0.000111	CbGpPWpGaD
Ziprasidone—ADRA2A—Hemostasis—TP53—adrenal gland cancer	8.63e-05	0.000109	CbGpPWpGaD
Ziprasidone—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	8.62e-05	0.000109	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TERT—adrenal gland cancer	8.59e-05	0.000109	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	8.51e-05	0.000108	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	8.47e-05	0.000107	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	8.45e-05	0.000107	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TERT—adrenal gland cancer	8.43e-05	0.000107	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	8.41e-05	0.000107	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	8.38e-05	0.000106	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	8.3e-05	0.000105	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	8.27e-05	0.000105	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	8.23e-05	0.000104	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	8.13e-05	0.000103	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	8.1e-05	0.000103	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—POMC—adrenal gland cancer	8.04e-05	0.000102	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	8.02e-05	0.000102	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.89e-05	0.0001	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	7.84e-05	9.95e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	7.8e-05	9.9e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	7.78e-05	9.86e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	7.76e-05	9.84e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	7.75e-05	9.82e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	7.71e-05	9.77e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	7.69e-05	9.75e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	7.59e-05	9.62e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	7.56e-05	9.59e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	7.56e-05	9.58e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	7.51e-05	9.52e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	7.51e-05	9.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	7.5e-05	9.5e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—BAD—adrenal gland cancer	7.47e-05	9.47e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	7.47e-05	9.47e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	7.47e-05	9.47e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	7.46e-05	9.46e-05	CbGpPWpGaD
Ziprasidone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	7.46e-05	9.45e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	7.38e-05	9.35e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—POMC—adrenal gland cancer	7.37e-05	9.35e-05	CbGpPWpGaD
Ziprasidone—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	7.37e-05	9.34e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	7.35e-05	9.32e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	7.35e-05	9.32e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—BAD—adrenal gland cancer	7.34e-05	9.3e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	7.31e-05	9.27e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.29e-05	9.24e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	7.29e-05	9.24e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	7.27e-05	9.21e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	7.24e-05	9.18e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	7.23e-05	9.17e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	7.22e-05	9.15e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	7.2e-05	9.13e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	7.15e-05	9.07e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	7.14e-05	9.05e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	7.13e-05	9.05e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	7e-05	8.88e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—POMC—adrenal gland cancer	6.89e-05	8.73e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	6.83e-05	8.66e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	6.8e-05	8.62e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	6.78e-05	8.59e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—POMC—adrenal gland cancer	6.76e-05	8.57e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—POMC—adrenal gland cancer	6.76e-05	8.57e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	6.74e-05	8.55e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	6.72e-05	8.52e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	6.69e-05	8.49e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	6.69e-05	8.48e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	6.68e-05	8.47e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	6.66e-05	8.44e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	6.65e-05	8.44e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	6.64e-05	8.41e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	6.64e-05	8.41e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	6.59e-05	8.36e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	6.57e-05	8.33e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	6.55e-05	8.31e-05	CbGpPWpGaD
Ziprasidone—DRD5—Signaling Pathways—TP53—adrenal gland cancer	6.52e-05	8.26e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	6.51e-05	8.26e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	6.49e-05	8.22e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	6.47e-05	8.21e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	6.45e-05	8.18e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	6.43e-05	8.15e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	6.42e-05	8.15e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Metabolism—PTGS2—adrenal gland cancer	6.41e-05	8.13e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	6.37e-05	8.08e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	6.35e-05	8.05e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	6.17e-05	7.82e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	6.09e-05	7.72e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—GNAS—adrenal gland cancer	6.05e-05	7.67e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	5.99e-05	7.6e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	5.99e-05	7.59e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	5.95e-05	7.54e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	5.93e-05	7.52e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	5.9e-05	7.48e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	5.88e-05	7.46e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	5.82e-05	7.38e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	5.8e-05	7.35e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.76e-05	7.3e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	5.73e-05	7.26e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	5.65e-05	7.17e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	5.6e-05	7.1e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	5.57e-05	7.06e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	5.42e-05	6.87e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	5.41e-05	6.86e-05	CbGpPWpGaD
Ziprasidone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	5.39e-05	6.83e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	5.33e-05	6.76e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	5.16e-05	6.54e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	5.09e-05	6.45e-05	CbGpPWpGaD
Ziprasidone—HTR6—Signaling Pathways—TP53—adrenal gland cancer	5.03e-05	6.38e-05	CbGpPWpGaD
Ziprasidone—HTR7—Signaling Pathways—TP53—adrenal gland cancer	5.03e-05	6.37e-05	CbGpPWpGaD
Ziprasidone—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	4.99e-05	6.33e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	4.92e-05	6.23e-05	CbGpPWpGaD
Ziprasidone—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	4.89e-05	6.2e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.84e-05	6.13e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	4.83e-05	6.12e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	4.81e-05	6.1e-05	CbGpPWpGaD
Ziprasidone—DRD4—Signaling Pathways—TP53—adrenal gland cancer	4.81e-05	6.1e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—POMC—adrenal gland cancer	4.8e-05	6.09e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	4.8e-05	6.08e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	4.75e-05	6.02e-05	CbGpPWpGaD
Ziprasidone—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	4.75e-05	6.02e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.74e-05	6e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.67e-05	5.92e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	4.59e-05	5.83e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.58e-05	5.81e-05	CbGpPWpGaD
Ziprasidone—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	4.54e-05	5.76e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	4.44e-05	5.62e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	4.41e-05	5.6e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	4.4e-05	5.58e-05	CbGpPWpGaD
Ziprasidone—DRD1—Signaling Pathways—TP53—adrenal gland cancer	4.33e-05	5.49e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	4.29e-05	5.44e-05	CbGpPWpGaD
Ziprasidone—DRD3—Signaling Pathways—TP53—adrenal gland cancer	4.27e-05	5.42e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	4.22e-05	5.36e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—POMC—adrenal gland cancer	4.07e-05	5.16e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	3.89e-05	4.94e-05	CbGpPWpGaD
Ziprasidone—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	3.86e-05	4.89e-05	CbGpPWpGaD
Ziprasidone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.83e-05	4.86e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	3.83e-05	4.86e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	3.82e-05	4.85e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	3.81e-05	4.83e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	3.8e-05	4.82e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	3.76e-05	4.77e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	3.75e-05	4.76e-05	CbGpPWpGaD
Ziprasidone—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	3.72e-05	4.72e-05	CbGpPWpGaD
Ziprasidone—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	3.71e-05	4.7e-05	CbGpPWpGaD
Ziprasidone—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	3.6e-05	4.57e-05	CbGpPWpGaD
Ziprasidone—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	3.55e-05	4.5e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	3.49e-05	4.42e-05	CbGpPWpGaD
Ziprasidone—DRD2—Signaling Pathways—TP53—adrenal gland cancer	3.27e-05	4.15e-05	CbGpPWpGaD
Ziprasidone—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	3.25e-05	4.12e-05	CbGpPWpGaD
Ziprasidone—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	3.22e-05	4.08e-05	CbGpPWpGaD
Ziprasidone—HRH1—Signaling Pathways—TP53—adrenal gland cancer	3.21e-05	4.07e-05	CbGpPWpGaD
Ziprasidone—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	3.2e-05	4.06e-05	CbGpPWpGaD
Ziprasidone—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	3.19e-05	4.04e-05	CbGpPWpGaD
Ziprasidone—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	3.16e-05	4.01e-05	CbGpPWpGaD
Ziprasidone—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	3.15e-05	3.99e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.14e-05	3.98e-05	CbGpPWpGaD
Ziprasidone—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	2.93e-05	3.71e-05	CbGpPWpGaD
Ziprasidone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.51e-05	3.18e-05	CbGpPWpGaD
